6 Reasons Why AGP Could Rise to PKR 265 Soon

AGP Limited (AGP) is showing clear company specific momentum that differentiates it from the broader pharmaceutical space. Its earnings growth, margin structure, and product mix provide a strong basis for revaluation. Based on the detailed AGP analysis in the 2026 strategy report, there are six concrete reasons supporting a move toward PKR 265.

1: AGP Has the Highest Gross Margins in the Listed Pharma Space

Margins Are Well Above Industry Levels

AGP reported a gross margin of 58.3 percent in 9MCY25, the highest among listed pharmaceutical companies. The industry average remains close to 40 percent.

📢 Announcement: You can now access our services and similar analyses by opening an account with us via JS Global

This margin advantage is driven by strong brands, favorable pricing power, and operational efficiencies rather than one off factors.

Margin Sustainability Is High

Management expects gross margins to remain near 60 percent going forward. Further stability is expected as consolidated operations mature.

Gross Margin Comparison

⚠️ This post reflects the author’s personal opinion and is for informational purposes only. It does not constitute financial advice. Investing involves risk and should be done independently. Read full disclaimer →